ArticleFrontiers in pharmacology2026
ETV6-NTRK3 as a resistance mechanism to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors: favorable response after combination of osimertinib and entrectinib: a case report and literature review.
Wei Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.